Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
fentaNYL
fentaNYL
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 12 mcg/hr | ||||||
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 25 mcg/hr | ||||||
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 50 mcg/hr | ||||||
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 75 mcg/hr | ||||||
| FentaNYL | FILM, EXTENDED RELEASE, TRANSDERMAL | 100 mcg/hr | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 200 mcg | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 400 mcg | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 600 mcg | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 800 mcg | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 1200 mcg | ||||||
| FentaNYL Citrate | LOZENGE, ORAL TRANSMUCOSAL | 1600 mcg | ||||||
| FentaNYL Citrate | SOLUTION, INJECTABLE | 10 mcg/mL-0.9% | ||||||
| FentaNYL Citrate | SOLUTION, INJECTABLE | 50 mcg/mL | ||||||
| Fentora | TABLET, BUCCAL | 200 mcg |
Last updated: Aug. 22, 2022
- Black Box Warning: Buccal Table & Injection: Serious adverse events, deaths; abuse potential
- Black Box Warning: Nasal Spray: Schedule II Controlled Substance: Abuse potential
- Black Box Warning: Sublingual Spray: Risk of respiratory depression, medication errors, abuse potential
- Black Box Warning: Transdermal: High concentration of Schedule II opioid agonist
- Do Not Crush: Slow-release Lozenge - Note: this lollipop delivery system requires the patient to slowly dissolve in mouth
- REMS: View FDA REMS Info
- REMS: FDA Med Guide Comprehensive List
Rhazdrugs: fentaNYL
BLACK BOX WARNING : Fentanyl Transmuscosal - Risk of Respiratory Depression, Medication Errors and Abuse